Patients with chronic obstructive pulmonary disease (COPD) and reduced physical activity showed a higher risk of emergency department visits or hospitalizations in a recent study. Patients with ...
Treatment with Nucala, an interleukin-5 antagonist monoclonal antibody, significantly reduced exacerbations leading to hospitalizations and emergency department visits. The Food and Drug ...
PhD Candidate in Management (concentration in Health Systems), L’Université d’Ottawa/University of Ottawa Andrew D. Scarffe (he/him) received funding from the Asthma Research Group Windsor-Essex ...
I overheard the EMS radio calling in to the emergency department and could immediately hear the urgency in the voice of the paramedic about a patient being brought in. He told us they were bringing in ...
GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results